Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

NYSE:CXW - New York Stock Exchange, Inc. - US21871N1019 - Common Stock - Currency: USD

19.07  -0.1 (-0.52%)

After market: 18.4518 -0.62 (-3.24%)

Fundamental Rating

4

Overall CXW gets a fundamental rating of 4 out of 10. We evaluated CXW against 84 industry peers in the Commercial Services & Supplies industry. CXW has an average financial health and profitability rating. While showing a medium growth rate, CXW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CXW was profitable.
In the past year CXW had a positive cash flow from operations.
CXW had positive earnings in 4 of the past 5 years.
In the past 5 years CXW always reported a positive cash flow from operatings.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

CXW has a better Return On Assets (2.35%) than 60.71% of its industry peers.
Looking at the Return On Equity, with a value of 4.61%, CXW is in line with its industry, outperforming 57.14% of the companies in the same industry.
CXW has a Return On Invested Capital (5.17%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CXW is significantly below the industry average of 10.07%.
The 3 year average ROIC (4.72%) for CXW is below the current ROIC(5.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.35%
ROE 4.61%
ROIC 5.17%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

CXW has a better Profit Margin (3.51%) than 64.29% of its industry peers.
In the last couple of years the Profit Margin of CXW has declined.
The Operating Margin of CXW (9.59%) is better than 69.05% of its industry peers.
In the last couple of years the Operating Margin of CXW has declined.
Looking at the Gross Margin, with a value of 23.87%, CXW is doing worse than 64.29% of the companies in the same industry.
In the last couple of years the Gross Margin of CXW has declined.
Industry RankSector Rank
OM 9.59%
PM (TTM) 3.51%
GM 23.87%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

CXW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CXW has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CXW has less shares outstanding
The debt/assets ratio for CXW has been reduced compared to a year ago.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.71, we must say that CXW is in the distress zone and has some risk of bankruptcy.
CXW's Altman-Z score of 1.71 is in line compared to the rest of the industry. CXW outperforms 42.86% of its industry peers.
CXW has a debt to FCF ratio of 4.98. This is a neutral value as CXW would need 4.98 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.98, CXW is doing good in the industry, outperforming 67.86% of the companies in the same industry.
A Debt/Equity ratio of 0.65 indicates that CXW is somewhat dependend on debt financing.
CXW has a Debt to Equity ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.98
Altman-Z 1.71
ROIC/WACC0.66
WACC7.87%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.57 indicates that CXW should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.57, CXW is doing good in the industry, outperforming 61.90% of the companies in the same industry.
CXW has a Quick Ratio of 1.57. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, CXW is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.39% over the past year.
Measured over the past years, CXW shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.17% on average per year.
CXW shows a small growth in Revenue. In the last year, the Revenue has grown by 3.43%.
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)3.39%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%-26.09%
Revenue 1Y (TTM)3.43%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%-2.43%

3.2 Future

The Earnings Per Share is expected to grow by 36.38% on average over the next years. This is a very strong growth
Based on estimates for the next years, CXW will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y12.89%
EPS Next 2Y36.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.29%
Revenue Next 2Y6.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 31.26 indicates a quite expensive valuation of CXW.
The rest of the industry has a similar Price/Earnings ratio as CXW.
CXW's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
Based on the Price/Forward Earnings ratio of 27.69, the valuation of CXW can be described as expensive.
CXW's Price/Forward Earnings is on the same level as the industry average.
CXW's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 31.26
Fwd PE 27.69
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXW is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
CXW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CXW is cheaper than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.58
EV/EBITDA 9.44
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CXW does not grow enough to justify the current Price/Earnings ratio.
CXW's earnings are expected to grow with 36.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.43
PEG (5Y)N/A
EPS Next 2Y36.38%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXW!.
Industry RankSector Rank
Dividend Yield N/A

CORECIVIC INC

NYSE:CXW (3/7/2025, 8:16:57 PM)

After market: 18.4518 -0.62 (-3.24%)

19.07

-0.1 (-0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-06 2025-05-06
Inst Owners91.92%
Inst Owner Change1.41%
Ins Owners1.74%
Ins Owner Change5.88%
Market Cap2.08B
Analysts82.5
Price Target28.56 (49.76%)
Short Float %3.26%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.04%
Min EPS beat(2)68.32%
Max EPS beat(2)113.77%
EPS beat(4)3
Avg EPS beat(4)41.6%
Min EPS beat(4)-47.19%
Max EPS beat(4)113.77%
EPS beat(8)5
Avg EPS beat(8)21.24%
EPS beat(12)7
Avg EPS beat(12)12.06%
EPS beat(16)9
Avg EPS beat(16)-5.12%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.02%
Max Revenue beat(2)3.59%
Revenue beat(4)4
Avg Revenue beat(4)2.51%
Min Revenue beat(4)0.7%
Max Revenue beat(4)3.73%
Revenue beat(8)5
Avg Revenue beat(8)0.58%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.66%
PT rev (1m)6.06%
PT rev (3m)15.7%
EPS NQ rev (1m)-22.92%
EPS NQ rev (3m)-19.07%
EPS NY rev (1m)-16.65%
EPS NY rev (3m)-20.54%
Revenue NQ rev (1m)1.2%
Revenue NQ rev (3m)1.2%
Revenue NY rev (1m)-0.84%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE 31.26
Fwd PE 27.69
P/S 1.07
P/FCF 10.58
P/OCF 7.78
P/B 1.4
P/tB 1.41
EV/EBITDA 9.44
EPS(TTM)0.61
EY3.2%
EPS(NY)0.69
Fwd EY3.61%
FCF(TTM)1.8
FCFY9.45%
OCF(TTM)2.45
OCFY12.85%
SpS17.86
BVpS13.59
TBVpS13.55
PEG (NY)2.43
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.35%
ROE 4.61%
ROCE 7.11%
ROIC 5.17%
ROICexc 5.39%
ROICexgc 5.4%
OM 9.59%
PM (TTM) 3.51%
GM 23.87%
FCFM 10.09%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.98
Debt/EBITDA 3.08
Cap/Depr 55.6%
Cap/Sales 3.63%
Interest Coverage 2.42
Cash Conversion 85.12%
Profit Quality 287.48%
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 1.71
F-Score8
WACC7.87%
ROIC/WACC0.66
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.39%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%-26.09%
EPS Next Y12.89%
EPS Next 2Y36.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.43%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%-2.43%
Revenue Next Year2.29%
Revenue Next 2Y6.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.18%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year98.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.48%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y16.06%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%